Tao received his B.S. from Wuhan University in China and earned his Ph.D. in medicinal chemistry from the University of Virginia, under the supervision of Professor Timothy Macdonald. His Ph.D. work focused on chemical biology study of Sphingosine 1-Phosphate (S1P) receptors and Sphingosine Kinases for immune modulation, which is directly relevant to human diseases such as autoimmune disorder and cancer. During his post-doc training in UVA’s School of Medicine, he extended his expertise into molecular imaging and nanotechnology for cancer diagnosis and therapy. In the Hsu lab, Tao will be working on immunotherapy for cancers.